NCT07284433
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07284433
Title Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies (QUADvance)
Acronym QUADvance
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AvenCell Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | DEU

Facility Status City State Zip Country Details
University of Chicago NOT_YET_RECRUITING Chicago Illinois 60637 United States Details
Northwestern University NOT_YET_RECRUITING Evanston Illinois 60208 United States Details
Brown University Health NOT_YET_RECRUITING Providence Rhode Island 02903 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
Universitätsklinikum Ulm RECRUITING Ulm Baden-Wurttemberg 89081 Germany Details
Universitätsklinikum Erlangen RECRUITING Erlangen Bavaria 91054 Germany Details
Klinikum der Universität München NOT_YET_RECRUITING Munich Bavaria 81377 Germany Details
Universitätsklinikum Marburg NOT_YET_RECRUITING Marburg Hesse 35032 Germany Details
Uniklinikum Erlangen NOT_YET_RECRUITING Essen North Rhine-Westphalia 45147 Germany Details
Universitätsklinikum Dresden RECRUITING Dresden Saxony 01307 Germany Details
Charité Universitätsmedizin Berlin RECRUITING Berlin 13353 Germany Details
Universitätsklinikum Hamburg-Eppendorf NOT_YET_RECRUITING Hamburg 20246 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field